Skip to main content

Sign up for our newsletter.

Quality journalism. Progressive values. Direct to your inbox.

People receive the Pfizer vaccine in West Africa

People queue to receive a Pfizer Covid-19 vaccine dose at the Ajame main market on August 27, 2021 during a Covid-19 vaccination campaign in Abidjan, Côte d'Ivoire. (Photo: Issouf Sanogo/AFP via Getty Images)

Concerning New Covid Variant Spotlights Dangers of Vaccine Apartheid

"This variant exemplifies that if you leave some of the world's population without access to vaccines, then the virus will continue to multiply and it will lead to more variants."

Jake Johnson

The detection of an unusual—and potentially more contagious—Covid-19 variant is intensifying fears that denying vaccines to large swaths of the world's population could allow the coronavirus to mutate unabated, prolonging the pandemic indefinitely and adding to the staggering global death toll.

"Every day, there are six times more boosters administered globally than primary doses in low-income countries. This is a scandal."

While the highly infectious Delta strain remains the dominant mutation around the world, the Jerusalem Post reported over the weekend that a variant known as B.1.640 has drawn the attention of experts "because there are changes to the coronavirus spike protein that have never been seen before."

The strain has thus far been detected in several European countries as well as on the largely unvaccinated African continent, where scientists say the strain may have originated.

"This lineage has a large number of recent sequences in France and the Congo with additional sequences in Switzerland, Italy, the U.K., and the USA," virologist Tom Peacock noted on Twitter.

Speaking to the Jerusalem Post, Bar-Ilan University Professor Cyrille Cohen warned that "this variant exemplifies that if you leave some of the world's population without access to vaccines, then the virus will continue to multiply and it will lead to more variants."

"Not giving vaccines to these countries may seem OK in the short term, but in the long term we might have new variants that are problematic that developed in unvaccinated countries," said Cohen. "I don't want to frighten people. There are just a few cases of B.1.640 now and it could very well be that in a month we could all forget about this variant."

"But it is an example of what could happen if there isn't access to vaccines for everyone," he added.

The World Health Organization is currently monitoring six coronavirus mutations that have been detected around the world, often emanating from countries—including India, Brazil, and South Africa—that have struggled to vaccinate their populations due to artificial shortages of doses or key materials.

While some middle- and low-income countries have ramped up their vaccination campaigns in recent months, much of Africa and other developing regions across the globe remain almost entirely without access to lifesaving shots.

"Less than 6% of the population in African states is vaccinated against coronavirus," notes a report published last week by the Economist Intelligence Unit (EIU). "In many countries, including Burkina Faso, Cameroon, Chad, Ethiopia, Guinea Bissau, Mali, Nigeria, and Tanzania, vaccination rates are even lower (at only around 1%), with little prospect of these picking up any time soon."

The report continues:

The cause of such low vaccination rates is well-known: despite recent improvements, global production continues to lag behind demand, with developing countries facing long delays in accessing vaccines. Meanwhile, global solidarity is ineffective; so far, COVAX has shipped only around 400 million doses of vaccines globally (compared with an initial target of delivering 1.9 billion doses in 2021). Donations from richer countries are also failing to materialize; as [of] late October, developed countries had delivered only 43 million doses of vaccines (out of pledges totaling about 400 million—which is still far below needs).

In a speech last week, WHO Director-General Tedros Adhanom Ghebreyesus warned that "nearly 80 countries, half of them in Africa, will not reach our 40% vaccination target" by the end of the year.

"Countries with the highest vaccine coverage continue to stockpile more vaccines, while low-income countries continue to wait," Tedros said. "Every day, there are six times more boosters administered globally than primary doses in low-income countries. This is a scandal that must stop now."

Deeply unequal access to vaccines—often dubbed "vaccine apartheid" by public health campaigners and the leaders of vulnerable countries—is a major reason the coronavirus is still killing an average of 7,000 people each day. Our World in Data estimates that 7.5 billion coronavirus vaccine doses have been administered worldwide, but just 4.5% of people in low-income countries have received at least one shot.

In the face of such persistent inequities, the leaders of rich countries are facing growing pressure to force pharmaceutical companies to share vaccine recipes with manufacturers around the world, a move proponents say is necessary to quickly increase regional production and distribution.

Thus far, pharmaceutical companies such as Moderna and Pfizer—profiting immensely from their government-granted monopolies—have refused to voluntarily share their technology with developing countries.

Vox's Umair Irfan argued last week that the massive and persistent vaccination gap "isn't just a humanitarian crisis, it's a global threat to the fragile progress already made in the pandemic."

"The longer the pandemic rages," Irfan wrote, "the greater the chances of a dangerous mutation in the coronavirus that causes Covid-19, which could then spread around the world."


Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.

... We've had enough. The 1% own and operate the corporate media. They are doing everything they can to defend the status quo, squash dissent and protect the wealthy and the powerful. The Common Dreams media model is different. We cover the news that matters to the 99%. Our mission? To inform. To inspire. To ignite change for the common good. How? Nonprofit. Independent. Reader-supported. Free to read. Free to republish. Free to share. With no advertising. No paywalls. No selling of your data. Thousands of small donations fund our newsroom and allow us to continue publishing. Can you chip in? We can't do it without you. Thank you.

'Utterly Obscene': Just 8 Pfizer and Moderna Investors Became $10 Billion Richer After Omicron Emerged

"Pharma execs and shareholders are making a killing from a crisis they helped to create," said one justice campaigner.

Jon Queally ·


Ilhan Omar Calls Kevin McCarthy 'A Liar and a Coward' for Refusing to Condemn Boebert's Islamophobia

"This is who they are," said the Minnesota Democrat. "And we have to be able to stand up to them. And we have to push them to reckon with the fact their party right now is normalizing anti-Muslim bigotry."

Jon Queally ·


'Congress Must Act': Bernie Sanders Demands End of Filibuster to Codify Abortion Rights

"We must pass legislation that codifies Roe v. Wade as the law of the land in this country. And if there aren't 60 votes to do it, and there are not, we must reform the filibuster to pass it with 50 votes."

Jon Queally ·


Human Rights Defenders Warn Biden Border Policy 'Quickly Transforming Into Trump 2.0'

Like his predecessor, President Joe Biden now being accused of "using racist, xenophobic tropes about immigrants to weaponize Covid-19 against migrants and asylum-seekers."

Jon Queally ·


'Bombshell': Israeli Spyware Used to Hack iPhones of US State Department Officials

Calling the Israel-based spyware maker NSO Group an "in-plain-sight national security threat," one expert warned that "a multi-agency investigation is immediately needed."

Jessica Corbett ·

Support our work.

We are independent, non-profit, advertising-free and 100% reader supported.

Subscribe to our newsletter.

Quality journalism. Progressive values.
Direct to your inbox.

Subscribe to our Newsletter.


Common Dreams, Inc. Founded 1997. Registered 501(c3) Non-Profit | Privacy Policy
Common Dreams Logo